Skip to main content
logo
Assembly Biosciences, Inc. (ASMB)
NASDAQ: ASMB · Real-Time Price · USD
25.91
+0.36 (1.41%)
Jul 27, 2026, 4:00 PM EDT - Market closed

Assembly Biosciences Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
71.172.328.527.16-6.25
Revenue Growth
121.11%153.52%298.16%---92.09%
Gross Profit
71.172.328.527.16-6.25
Operating Income
-13.55-12.12-45.42-64.65-94.11-132.69
Net Income
-6.38-6.12-40.18-61.23-93.09-129.86
Earnings Per Share
-0.11-0.55-6.69-13.38-23.08-36.00
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
226.6248.11112.08130.2591.61146.63
Total Debt
2.492.633.092.343.476.48
Net Cash (Debt)
224.11245.48108.99127.9188.15140.15
Net Cash Growth
154.65%125.23%-14.79%45.11%-37.11%-32.06%
Net Cash Per Share
16.5521.9018.1527.9421.8538.86

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-39.75-41.09-51.1222.74-84.46-93.4
Capital Expenditures
--0.07-0.03-0.26-0.1-3.1
Free Cash Flow
-39.75-41.16-51.1522.49-84.57-96.49
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%-100.00%
Operating Margin
-19.05%-16.76%-159.26%-902.50%--2121.65%
Pretax Margin
3.79%-8.47%-139.72%-854.32%--2116.82%
Profit Margin
3.79%-8.47%-140.87%-854.78%--2157.29%
FCF Margin
-55.91%-56.93%-179.33%313.95%--1542.88%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
P/FCF Ratio
---2.40--
PS Ratio
7.027.464.137.53-17.93